Published in J Rheumatol on June 15, 2013
Regulation of B lymphocytes and plasma cells by innate immune mechanisms and stromal cells in rheumatoid arthritis. Expert Rev Clin Immunol (2014) 0.81
Expression of B cell activating factor (BAFF) and BAFF-binding receptors in rheumatoid arthritis. J Rheumatol (2013) 0.81
Surface APRIL Is Elevated on Myeloid Cells and Is Associated with Disease Activity in Patients with Rheumatoid Arthritis. J Rheumatol (2015) 0.79
Therapeutic effects of PADRE-BAFF autovaccine on rat adjuvant arthritis. Biomed Res Int (2014) 0.78
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis. Nat Commun (2016) 0.76
Expression of the inherently autoreactive idiotope 9G4 on autoantibodies to citrullinated peptides and on rheumatoid factors in patients with early and established rheumatoid arthritis. PLoS One (2014) 0.75
B-cell phenotype and IgD-CD27- memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis. PLoS One (2017) 0.75
Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J Immunol (2004) 3.62
Regulation of the germinal center reaction by Foxp3+ follicular regulatory T cells. J Immunol (2011) 2.27
Induced IL-17-producing invariant NKT cells require activation in presence of TGF-β and IL-1β. J Immunol (2013) 2.21
Critical influence of natural regulatory CD25+ T cells on the fate of allografts in the absence of immunosuppression. Transplantation (2005) 1.66
Dominant transplantation tolerance impairs CD8+ T cell function but not expansion. Nat Immunol (2002) 1.55
EpiReumaPt- the study of rheumatic and musculoskeletal diseases in Portugal: a detailed view of the methodology. Acta Reumatol Port (2015) 1.43
The Portuguese Society of Rheumatology position paper on the use of biosimilars. Acta Reumatol Port (2014) 1.42
Osteoblasts and bone formation. Acta Reumatol Port (2007) 1.34
Immune privilege induced by regulatory T cells in transplantation tolerance. Immunol Rev (2006) 1.27
Sub-optimal CD4+ T-cell activation triggers autonomous TGF-β-dependent conversion to Foxp3+ regulatory T cells. Eur J Immunol (2011) 1.27
Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanisms. Immunol Rev (2003) 1.26
Regulatory T cells overexpress a subset of Th2 gene transcripts. J Immunol (2002) 1.25
Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis. Arthritis Res Ther (2010) 1.25
Regulatory T cells and organ transplantation. Semin Immunol (2004) 1.22
Identification of regulatory Foxp3+ invariant NKT cells induced by TGF-beta. J Immunol (2010) 1.21
Regulatory T cells in transplantation. Semin Immunol (2006) 1.10
Comparative effectiveness and predictors of response to tumour necrosis factor inhibitor therapies in rheumatoid arthritis. Rheumatology (Oxford) (2012) 1.04
Whole blood transcriptional profiling in ankylosing spondylitis identifies novel candidate genes that might contribute to the inflammatory and tissue-destructive disease aspects. Arthritis Res Ther (2011) 1.01
Bilateral MR imaging of the hand and wrist in early and very early inflammatory arthritis: tenosynovitis is associated with progression to rheumatoid arthritis. Radiology (2012) 0.96
Modulation of IL-17 and Foxp3 expression in the prevention of autoimmune arthritis in mice. PLoS One (2010) 0.92
Alterations on peripheral blood B-cell subpopulations in very early arthritis patients. Rheumatology (Oxford) (2010) 0.92
[Tuberculosis in rheumatic patients treated with tumour necrosis factor alpha antagonists: the Portuguese experience]. Acta Reumatol Port (2006) 0.90
Chronic arthritis leads to disturbances in the bone collagen network. Arthritis Res Ther (2010) 0.90
Rheumatoid arthritis bone fragility is associated with upregulation of IL17 and DKK1 gene expression. Clin Rev Allergy Immunol (2014) 0.89
Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoter. Arthritis Res Ther (2007) 0.89
Early vascular alterations in SLE and RA patients--a step towards understanding the associated cardiovascular risk. PLoS One (2012) 0.88
Primary biliary cirrhosis in a rheumatoid arthritis patient treated with rituximab, a case-based review. Clin Rheumatol (2011) 0.88
Portuguese guidelines for the use of biological agents in rheumatoid arthritis - October 2011 update. Acta Reumatol Port (2012) 0.87
Cytokine pattern in very early rheumatoid arthritis favours B-cell activation and survival. Rheumatology (Oxford) (2010) 0.87
Mechanisms Underlying CD4+ Treg Immune Regulation in the Adult: From Experiments to Models. Front Immunol (2013) 0.86
Regulatory T cells in the induction and maintenance of peripheral transplantation tolerance. Transpl Int (2003) 0.86
Upregulation of inflammatory genes and downregulation of sclerostin gene expression are key elements in the early phase of fragility fracture healing. PLoS One (2011) 0.85
Low osteocalcin/collagen type I bone gene expression ratio is associated with hip fragility fractures. Bone (2012) 0.84
Osteomesopyknosis: an incidental discovery due to back pain. Joint Bone Spine (2012) 0.83
Adjuvant facilitates tolerance induction to factor VIII in hemophilic mice through a Foxp3-independent mechanism that relies on IL-10. Blood (2013) 0.83
Anti-ribosomal P protein IgG autoantibodies in patients with systemic lupus erythematosus: diagnostic performance and clinical profile. BMC Med (2013) 0.83
Tumor necrosis factor-alpha -308 genotypes influence inflammatory activity and TNF-alpha serum concentrations in children with juvenile idiopathic arthritis. J Rheumatol (2009) 0.83
Dynamic contrast-enhanced 3-T magnetic resonance imaging: a method for quantifying disease activity in early polyarthritis. Skeletal Radiol (2011) 0.82
Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs? BMC Med (2013) 0.82
To B or not to B the conductor of rheumatoid arthritis orchestra. Clin Rev Allergy Immunol (2012) 0.81
Persistent low grade synovitis without erosive progression in magnetic resonance imaging of rheumatoid arthritis patients treated with infliximab over 1 year. Clin Rheumatol (2009) 0.81
[Protocol for evaluation and monitoring of Systemic Lupus Erythematosus (PAMLES)]. Acta Reumatol Port (2008) 0.81
Osteoporosis: from bone biology to individual treatment decision. Acta Med Port (2013) 0.81
High Pdr12 levels in spoilage yeast (Saccharomyces cerevisiae) correlate directly with sorbic acid levels in the culture medium but are not sufficient to provide cells with acquired resistance to the food preservative. Int J Food Microbiol (2006) 0.81
Lymphotoxin-α 252 A>G polymorphism: a link between disease susceptibility and dyslipidemia in rheumatoid arthritis? J Rheumatol (2011) 0.81
Three decades of low-dose methotrexate in rheumatoid arthritis: can we predict toxicity? Immunol Res (2014) 0.81
Prevalence of fatigue in a group of airline pilots. Aviat Space Environ Med (2013) 0.80
A FRAX model for the estimation of osteoporotic fracture probability in Portugal. Acta Reumatol Port (2013) 0.80
Portuguese guidelines for the use of biological agents in rheumatoid arthritis - March 2010 update. Acta Reumatol Port (2010) 0.79
CD4-blockade can induce protection from peanut-induced anaphylaxis. Front Immunol (2011) 0.79
EpiReumaPt Protocol - Portuguese epidemiologic study of the rheumatic diseases. Acta Reumatol Port (2010) 0.79
[Guidelines for the diagnosis and treatment of latent tuberculosis infection and active tuberculosis in patients with inflammatory joint diseases proposed for treatment with tumour necrosis factor alpha antagonist drugs]. Rev Port Pneumol (2006) 0.79
Regulatory T cell maintenance of dominant tolerance: induction of tissue self-defense? Transpl Immunol (2006) 0.79
EpiReumaPt: how to perform a national population based study - a practical guide. Acta Reumatol Port (2015) 0.78
From a neutrophilic synovial tissue infiltrate to a challenging case of rheumatoid arthritis. Acta Reumatol Port (2010) 0.78
Gender-specific effects of genetic variants within Th1 and Th17 cell-mediated immune response genes on the risk of developing rheumatoid arthritis. PLoS One (2013) 0.78
CoReumaPt protocol: the Portuguese cohort of rheumatic diseases. Acta Reumatol Port (2012) 0.78
Serial analysis of gene expression provides new insights into regulatory T cells. Semin Immunol (2003) 0.78
Genetic variants within immune-modulating genes influence the risk of developing rheumatoid arthritis and anti-TNF drug response: a two-stage case-control study. Pharmacogenet Genomics (2015) 0.78
T cell apoptosis and induction of Foxp3+ regulatory T cells underlie the therapeutic efficacy of CD4 blockade in experimental autoimmune encephalomyelitis. J Immunol (2012) 0.78
Rituximab use in pediatric autoimmune diseases: four case reports. Ann N Y Acad Sci (2009) 0.77
Regulatory T cells and the control of the allergic response. J Allergy (Cairo) (2012) 0.77
Prevention of house dust mite induced allergic airways disease in mice through immune tolerance. PLoS One (2011) 0.77
Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients. Arthritis Res Ther (2011) 0.77
Recommendations for the diagnosis and treatment of latent and active tuberculosis in inflammatory joint diseases candidates for therapy with tumor necrosis factor alpha inhibitors: March 2008 update. Acta Reumatol Port (2008) 0.77
Multidisciplinary Portuguese recommendations on DXA request and indication to treat in the prevention of fragility fractures. Acta Reumatol Port (2016) 0.77
Bilateral evaluation of the hand and wrist in untreated early inflammatory arthritis: a comparative study of ultrasonography and magnetic resonance imaging. J Rheumatol (2013) 0.76
[Eosinophilic fasciitis and aplastic anemia]. Acta Reumatol Port (2009) 0.76
Using the Juvenile Arthritis Disease Activity Score based on erythrocyte sedimentation rate or C-reactive protein level: results from the Portuguese register. Arthritis Care Res (Hoboken) (2014) 0.76
2011 Portuguese recommendations for the use of biological therapies in patients with psoriatic arthritis. Acta Reumatol Port (2012) 0.76